494 related articles for article (PubMed ID: 8683218)
1. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
[TBL] [Abstract][Full Text] [Related]
2. Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus.
Kroeger MA; McMinn PC
Arch Virol; 2002 Jun; 147(6):1155-72. PubMed ID: 12111426
[TBL] [Abstract][Full Text] [Related]
3. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
Colombage G; Hall R; Pavy M; Lobigs M
Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
5. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
6. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus.
Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213
[TBL] [Abstract][Full Text] [Related]
7. Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model.
Broom AK; Wallace MJ; Mackenzie JS; Smith DW; Hall RA
J Med Virol; 2000 Jun; 61(2):259-65. PubMed ID: 10797383
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of virus-specific RNA produced in the brains of flavivirus-susceptible and -resistant mice after challenge with Murray Valley encephalitis virus.
Urosevic N; van Maanen M; Mansfield JP; Mackenzie JS; Shellam GR
J Gen Virol; 1997 Jan; 78 ( Pt 1)():23-9. PubMed ID: 9010281
[TBL] [Abstract][Full Text] [Related]
9. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
Putnak JR; Schlesinger JJ
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
[TBL] [Abstract][Full Text] [Related]
10. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum.
Hall RA; Broom AK; Hartnett AC; Howard MJ; Mackenzie JS
J Virol Methods; 1995 Feb; 51(2-3):201-10. PubMed ID: 7738140
[TBL] [Abstract][Full Text] [Related]
11. [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein].
Timofeev AV; Kondrat'eva IuIu; Karganova GG; Stephenson J
Vopr Virusol; 2001; 46(1):22-4. PubMed ID: 11233282
[TBL] [Abstract][Full Text] [Related]
12. A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.
Mathews JH; Roehrig JT; Brubaker JR; Hunt AR; Allan JE
J Virol; 1992 Nov; 66(11):6555-62. PubMed ID: 1383567
[TBL] [Abstract][Full Text] [Related]
13. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein.
Clark DC; Lobigs M; Lee E; Howard MJ; Clark K; Blitvich BJ; Hall RA
J Gen Virol; 2007 Apr; 88(Pt 4):1175-1183. PubMed ID: 17374761
[TBL] [Abstract][Full Text] [Related]
14. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants.
Lobigs M; Arthur CE; Müllbacher A; Blanden RV
Virology; 1994 Jul; 202(1):195-201. PubMed ID: 7516597
[TBL] [Abstract][Full Text] [Related]
15. Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus.
Rumyantsev AA; Zhang ZX; Gao QS; Moretti N; Brown N; Kleanthous H; Delagrave S; Guirakhoo F; Collett MS; Pugachev KV
Virology; 2010 Jan; 396(2):329-38. PubMed ID: 19913267
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
Falgout B; Bray M; Schlesinger JJ; Lai CJ
J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
18. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
Pugachev KV; Mason PW; Shope RE; Frey TK
Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
[TBL] [Abstract][Full Text] [Related]
19. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
[TBL] [Abstract][Full Text] [Related]
20. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella.
Whittle BL; Lee E; Weir RC; Verma NK
J Med Microbiol; 1997 Feb; 46(2):129-38. PubMed ID: 9060872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
